Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03613038 · ClinicalTrials.gov registry record · NA
A Systematic Investigation of Phonetic Complexity Effects on Articulatory Motor Performance in Progressive Dysarthria
A NA study, sponsored by University of Missouri-Columbia.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT03613038 is a NA study that has completed, run by University of Missouri-Columbia. The registered enrollment target is 100 participants.
The verdict
NCT03613038, a NA study, has completed, sponsored by University of Missouri-Columbia.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
The goal is to improve the fundamental knowledge about articulatory motor performance in people with Lou Gehrig's disease (also known as ALS) and Parkinson's disease (PD), in order to develop more sensitive assessments for progressive speech loss, which may lead to the improved timing of speech therapies.
Interventions
- BEHAVIORAL Phonetic complexity effects on speech motor performance
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2017-07-15 |
| Est. Completion | 2022-02-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03613038
The ClinicalTrials.gov registry entry for NCT03613038 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Missouri-Columbia, which has 291 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Phonetic complexity effects on speech motor performance is the first listed.
NCT03613038 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03613038 about?
NCT03613038 is a clinical study titled "A Systematic Investigation of Phonetic Complexity Effects on Articulatory Motor Performance in Progressive Dysarthria". The goal is to improve the fundamental knowledge about articulatory motor performance in people with Lou Gehrig's disease (also known as ALS) and Parkinson's disease (PD), in order to develop more sensitive assessments for progressive speech loss, which may lead to the improved timing of speech ther...
What is the current status of trial NCT03613038?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2017-07-15. Estimated completion is 2022-02-28.
What interventions are being tested in trial NCT03613038?
The interventions under investigation include: Phonetic complexity effects on speech motor performance (BEHAVIORAL).
Who is sponsoring clinical trial NCT03613038?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.